Epic Capital Management

They're excited about the future of human technology. Along with virtual reality, self-driving cars and voyages to Mars, medical and genetic engineering technologies will also flourish. In anticipation, they're cryopreserving young human cells as inputs and templates for use with our older bodies to help improve longevity.

ThoughtWire Corp. develops and markets an application platform for enterprise and cloud applications. The company was founded in 2009 and is based in Toronto, Canada.

InteraXon is the maker of brainwave-controlled computing technology and applications. They have created a hardware and software platform technology that converts brainwaves into digital signals that are fed into a computer. InteraXon then provides consumers with applications that use these brainwaves to perform activities such as meditation, gaming, ADHD assistance, and many others to come. The company was founded in 2007 and headquartered in Toronto, Ontario.

Cyclica Inc. is a biotechnology company based in Toronto, Canada, that focuses on improving the drug discovery process through an integrated cloud-based platform enhanced by artificial intelligence. The company's key technologies, Ligand Design and Ligand Express, facilitate the design of novel molecules and the screening of small-molecule drugs, respectively. Ligand Design generates compounds while filtering for desired molecular and pharmacokinetic properties, whereas Ligand Express assesses drug candidates against a range of structurally-characterized proteins to evaluate their poly-pharmacological profiles. Cyclica employs advanced technologies such as MatchMaker™, a deep learning proteome screening tool, and POEM™, a supervised learning system for predicting molecular properties, to prioritize compounds effectively. Founded by Jason Mitakidis and Naheed Kurji in 2013, Cyclica aims to address unmet medical needs by creating precision medicines through a decentralized approach to drug discovery. The company has also established a strategic partnership with AUM Biosciences to further its mission.

Circle Cardiovascular Imaging specializes in developing and marketing advanced software solutions for the post-processing of cardiovascular imaging, specifically for magnetic resonance imaging (MRI) and computed tomography (CT) images. Its primary products include cmr42 and ct42, which facilitate the analysis of cardiovascular MR and CT images, respectively, as well as cvi42, which integrates both modalities for comprehensive evaluations. Additionally, report42 aids in the documentation and reporting of these images. The software is designed to support the diagnosis and management of various cardiovascular conditions, including heart failure, coronary artery disease, and myocardial infarction, among others. Circle Cardiovascular Imaging also provides training, education services, and product support to enhance the user experience. Founded in 2007 and headquartered in Calgary, Canada, the company distributes its products through a global network, serving both clinical and research environments.

QoC Health Inc. develops a cloud-based digital platform to connect patients with healthcare providers. Its solutions include patient monitoring, research/clinical trials, compliance, and Hl7 integration; acute and chronic monitoring, wound care, post 30 day discharge, and patient education and decision aids; peer support, mental health, transitions in care, and social networks; and ambulatory and chronic care. The company was founded in 2010 and is headquartered in Toronto, Canada.

Perimeter Medical Imaging is a privately held medical device company with offices in Toronto, Canada. Our executive team of medical device leaders holds an excellent track record of successfully building companies and improving outcomes for clinicians and patients.

ChipCare Corporation, founded in 2009 and based in Toronto, Canada, specializes in developing point-of-care testing and monitoring systems for healthcare applications. The company aims to enhance access to advanced blood tests worldwide through its innovative handheld cell analyzer system, which can conduct multiple diagnostic tests from a single drop of blood. This includes cell counting, protein and enzyme analysis, and pathogen detection. ChipCare's solution integrates patient identification, blood testing, and quality management protocols, making it suitable for both resource-rich and resource-limited settings. The primary revenue stream is expected to come from the sale of disposable test slides, which are critical components of its diagnostic platform. This microfluidic technology enables healthcare providers to perform a variety of tests efficiently, facilitating timely diagnosis and treatment for patients in need.